UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008432
Receipt number R000009921
Scientific Title Investigation of diarrhea and Clostridium difficile-colitis after lung cancer chemotherapy
Date of disclosure of the study information 2012/07/29
Last modified on 2021/12/05 21:23:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of diarrhea and Clostridium difficile-colitis after lung cancer chemotherapy

Acronym

Lung cancer chemothrapy, diarrhea, and Clostridium difficile-colitis study

Scientific Title

Investigation of diarrhea and Clostridium difficile-colitis after lung cancer chemotherapy

Scientific Title:Acronym

Lung cancer chemothrapy, diarrhea, and Clostridium difficile-colitis study

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To estimate the incidence of diarrhea and Clostridium difficile-colitis after lung cancer chemotherapy

Basic objectives2

Others

Basic objectives -Others

To estimate the incidence of diarrhea and Clostridium difficile-colitis after lung cancer chemotherapy

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of diarrhea and Clostridium difficile-colitis after lung cancer chemotherapy

Key secondary outcomes

a preventive effect of probiotics against Clostridium difficile-colitis after lung cancer chemotherapy
an effect of treatment for Clostridium difficile-colitis after lung cancer chemotherapy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

an age of at least 20 years
histologically or cytologically confirmed lung cancer
scheduled for chemotherapy of TS-1, CPT-11, or taxane-anticancer drugs

an Eastern Corporative Oncology Group (ECOG) performance status of 3 or less
without diarrhea
a life expectancy of at least 3 months

Key exclusion criteria

ileus
diarrhea for more than three times a day before the administration of the anticancer agent
a history of Clostridium difficile infection in the 2 months before enrollment
mental disorders require the administration of antipsychotic
major complications interfere with the continuation of the treatment

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Shunichi
Middle name
Last name Sugawara

Organization

Sendai Kousei Hospital

Division name

respiratory medicine

Zip code

980-0873

Address

4-15,Hirosemachi,Aoba-ku,Sendai,Miyagai, Japan

TEL

81-22-222-6181

Email

swara357@cat-v.ne.jp


Public contact

Name of contact person

1st name Takao
Middle name
Last name Kobayashi

Organization

North Japan Lung Cancer Study Group

Division name

Sendai Kousei Hospital

Zip code

980-0873

Address

4-15,Hirosemachi,Aoba-ku,Sendai,Miyagai, Japan

TEL

81-22-222-6181

Homepage URL


Email

ktakao@cat-v.ne.jp


Sponsor or person

Institute

North Japan Lung Cancer Study Group

Institute

Department

Personal name



Funding Source

Organization

North Japan Lung Cancer Study Group

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sendai Kousei hospital

Address

4-15, Hirosemachi, Aoba-Ku, Sendai, Miyagi,Japan

Tel

81-22-222-6181

Email

yuktoi119@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 29 Day


Related information

URL releasing protocol

https://doi.org/10.3389/fonc.2021.685320

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.3389/fonc.2021.685320

Number of participants that the trial has enrolled

263

Results

Grade 2 or higher diarrhea was observed in 22 patients(8.4%); Clostridium difficile infection(CDI) was confirmed in five of them. The incidence of CDI was 22.7% of all diarrhea cases.

Results date posted

2021 Year 12 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

lung cancer chemotherapy patients

Participant flow

Participants were enrolled by each institutes.

Adverse events

not observed

Outcome measures

Grade 2 or higher diarrhea was observed in 22 patients(8.4%); Clostridium difficile infection(CDI) was confirmed in five of them. The incidence of CDI was 22.7% of all diarrhea cases.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 07 Month 01 Day

Date of IRB

2012 Year 09 Month 10 Day

Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date

2017 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

record the case of diarrhea after lung cancer chemotherapy


Management information

Registered date

2012 Year 07 Month 13 Day

Last modified on

2021 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009921


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name